FDA warns against compounded Semaglutide medicines
The FDA is warning people to avoid using compounded medicines as substitutes for the popular weight loss and diabetes drugs Ozempic, Rybelsus, and Wegovy. Compounded
The FDA is warning people to avoid using compounded medicines as substitutes for the popular weight loss and diabetes drugs Ozempic, Rybelsus, and Wegovy. Compounded
Metformin, a drug commonly used to treat diabetes, can reduce the risk of developing long COVID by over 40%, according to a study published in
While continuous glucose monitors (CGMs) can provide real-time data and alerts to help people with diabetes make informed decisions about their health, it has been
New research suggests that terminating metformin may raise the risk for dementia in older adults with Type 2 diabetes, providing more evidence of metformin’s potential
New data suggests that the glucose-lowering drug class sodium-glucose cotransporter-2 (SGLT2) inhibitors appear to reduce the risk for recurrent gout flares – and to lessen
Abbott has announced new data from a real-world evidence study in Sweden showing that the use of the FreeStyle Libre continuous glucose monitoring system (CGM)
Many people with diabetes experience diabetes distress, anxiety, or depression. In turn, depression is linked to chronic conditions like diabetes, high blood pressure, heart disease, arthritis,
People taking semaglutide or liraglutide for weight management are at a higher risk of rare but potentially serious gastrointestinal issues, compared with those taking naltrexone/bupropion,
The National Institute for Health and Clinical Excellence (NICE) has recommended tirzepatide (Mounjaro, produced by Eli Lilly) as a new treatment option for some people
Eli Lilly and Co has announced that it will buy privately held Versanis for potentially up to $1.93bn to strengthen its position in the fast-growing